Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Olema Pharmaceuticals Inc (NQ: OLMA ) 14.82 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 14.82 Bid (Size) 10.26 (1) Ask (Size) 15.00 (2) Prev. Close 14.82 Today's Range 14.82 - 14.82 52wk Range 7.780 - 17.79 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 02, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 04, 2024 From Olema Oncology Via GlobeNewswire Performance YTD +7.94% +7.94% 1 Month +24.75% +24.75% 3 Month +46.01% +46.01% 6 Month +30.11% +30.11% 1 Year +69.95% +69.95% More News Read More 12 Health Care Stocks Moving In Tuesday's Intraday Session June 04, 2024 Via Benzinga Olema Pharmaceuticals Inc. (NASDAQ: OLMA) Near the Top of Equities by Percentage Gain on 2/1 February 01, 2024 Via Investor Brand Network Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 03, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session June 03, 2024 Via Benzinga Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday June 03, 2024 Via Benzinga Olema Oncology to Participate in Upcoming Investor Conferences in June May 28, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress May 15, 2024 From Olema Oncology Via GlobeNewswire OLMA Stock Earnings: Olema Pharmaceuticals Misses EPS for Q1 2024 May 08, 2024 Via InvestorPlace Olema Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update May 08, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress May 08, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 02, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology to Participate in Upcoming Investor Conferences in May May 01, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference April 08, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 02, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update March 11, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Announces Publication of Data Highlighting Palazestrant’s Ability to Inhibit Wild-Type and Mutant ER+ Breast Cancer Both as Monotherapy and in Combination with CDK4/6 Inhibitors March 06, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 04, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology to Participate in Upcoming Investor Conferences February 06, 2024 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 02, 2024 From Olema Oncology Via GlobeNewswire Eaton Posts Strong Results, Joins Ferrari, Boot Barn And Other Big Stocks Moving Higher On Thursday February 01, 2024 Via Benzinga Topics Stocks Exposures US Equities Olema Oncology Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate January 08, 2024 From Olema Oncology Via GlobeNewswire Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 January 05, 2024 Via Investor's Business Daily Olema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference January 02, 2024 From Olema Oncology Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
